Picture of Metlife logo

MET Metlife News Story

0.000.00%
us flag iconLast trade - 00:00
FinancialsConservativeLarge CapSuper Stock

REG - T Stamp Inc - Trust Stamp receives approval for Nasdaq listing

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220127:nRSa9036Za&default-theme=true

RNS Number : 9036Z  T Stamp Inc  27 January 2022

T STAMP INC

('Trust Stamp' or 'The Company')

 

Trust Stamp receives approval for Nasdaq listing

 

27 January 2022: Trust Stamp (OTCQX: IDAI, Euronext Growth: AIID ID), a global
provider of AI-powered, privacy-first trust and identity services used across
multiple sectors, has received approval from Nasdaq to have its Class A Common
stock listed on the Nasdaq Capital Market under the symbol "IDAI" with trading
expected to commence on January 31, 2022. Prior to listing on Nasdaq, the
Company's shares continue to trade on the OTCQX® Best Market under the same
ticker symbol.

 

The company also reports it has filed its Form 8-A (the "Registration
Statement") with the Securities and Exchange Commission (the "SEC") and has
received SEC qualification of its Form 1-A (the "Offering Statement") for the
Regulation A offering in which existing investors have the ability to exercise
warrants.

 

The uplisting continues Trust Stamp's momentum in 2021 which included an
initial contract award of $3.92M from the United States Department of Homeland
Security, increased R&D, productization and business development resources
to meet growing demand across new geographies and verticals, and establishing
subsidiaries in Rwanda and the Isle of Man.

 

Trust Stamp CEO Gareth N. Genner comments: "Trust Stamp has raised over $30M
in capital, welcomed over 3,500 shareholders, and scaled to over 100
passionate team members in nine countries. We appreciate the tremendous
support of our shareholders, customers, and partners, which has enabled us to
achieve this incredible milestone of listing on Nasdaq, the pre-eminent
capital market for innovative technology companies.

We are committed to building significant long-term shareholder-value as we
execute on our mission of delivering accessible, privacy-first identity and
trust verification solutions that promote global societal and financial
inclusion."

Trust Stamp and its subsidiaries deliver unparalleled security and privacy
among biometric and digital identity solutions, taking a unique approach to
data tokenization with proven cross-industry applications. The Company's core
technology leverages deep neural networks in a patented process that turns any
biometric or other sensitive data into unique, anonymized representations
known as the Irreversibly Transformed Identity Tokens (IT
(https://truststamp.ai/Protect.html) (2 (https://truststamp.ai/Protect.html)
)) (https://truststamp.ai/Protect.html) that are safely stored, shared, and
utilized as accurate identifiers across use cases of any scale.

 

"Trust Stamp's competitive advantage versus the legacy biometrics industry
continues to garner commercial support across government and enterprise
security and fraud prevention, data protection and privacy, and financial
accessibility applications, which is reflected in our sustained year-over-year
growth despite exceptional market conditions. We look forward to further
strengthening our position as a trusted leader in the identity space with the
increased visibility and reputation that a Nasdaq listing affords," says Trust
Stamp President Andrew Gowasack

 

 

 

Enquiries

Trust Stamp
 
Email: Shareholders@truststamp.ai

Gareth Genner, Chief Executive
Officer

Nisha Naik, Executive VP of Communications

Davy (Euronext Growth Advisor)
 Tel: +353 1 679 6363

Barry Murphy

Investor
Relations
Tel: +1 212-671-1021

Crescendo
Communications
Email: idai@crescendo-ir.com

 

About Trust Stamp

Trust Stamp (https://truststamp.ai/) is a global provider of AI-powered
identity services for use in multiple sectors including banking and finance,
regulatory compliance, government, real estate, communications, and
humanitarian services. Its technology empowers organizations with advanced
biometric identity solutions that reduce fraud, protect personal data privacy,
increase operational efficiency, and reach a broader base of users worldwide
through its unique data transformation and comparison capabilities.

Located in seven countries across North America, Europe, Asia, and Africa,
Trust Stamp trades on the OTCQX Best Market (OTCQX: IDAI
(https://www.otcmarkets.com/stock/IDAI/overview) ) and Euronext Growth in
Dublin (Euronext Growth: AIID ID
(https://live.euronext.com/en/product/equities/US8730483000-XESM) ). Founded
in 2016 by Gareth Genner and Andrew Gowasack, the company now employs over 100
people.

 

Safe Harbor Statement: Caution Concerning Forward-Looking Remarks

All statements in this release that are not based on historical fact are
"forward-looking statements" including within the meaning of the Private
Securities Litigation Reform Act of 1995 and the provisions of Section 27A of
the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. The information in this announcement may
contain forward-looking statements and information related to, among other
things, the company, its business plan and strategy, and its industry. These
statements reflect management's current views with respect to future
events-based information currently available and are subject to risks and
uncertainties that could cause the company's actual results to differ
materially from those contained in the forward-looking statements. Investors
are cautioned not to place undue reliance on these forward-looking statements,
which speak only as of the date on which they are made. The company does not
undertake any obligation to revise or update these forward-looking statements
to reflect events or circumstances after such date or to reflect the
occurrence of unanticipated events.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ISEEAXFXAEDAEFA

Recent news on Metlife

See all news